MLH1 and endometrial cancer: MSI can occur spontaneously in 10–15% of colorectal and up to 25 to 35% of endometrial cancers, mainly due to somatic inactivation of the MMR genes by either biallelic hypermethylation of the MLH-1 promoter or by double somatic mutations in one of the MMR system genes.